277 related articles for article (PubMed ID: 9197875)
1. Long-term influence of different postmenopausal hormone replacement regimens on serum lipids and lipoprotein(a): a randomised study.
Hänggi W; Lippuner K; Riesen W; Jaeger P; Birkhäuser MH
Br J Obstet Gynaecol; 1997 Jun; 104(6):708-17. PubMed ID: 9197875
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects on serum lipoproteins by 17 beta-oestradiol-dydrogesterone therapy in postmenopausal women; a prospective study.
van der Mooren MJ; Demacker PN; Thomas CM; Rolland R
Eur J Obstet Gynecol Reprod Biol; 1992 Nov; 47(2):153-60. PubMed ID: 1459329
[TBL] [Abstract][Full Text] [Related]
3. Influence of two hormone replacement therapy regimens, oral oestradiol valerate and cyproterone acetate versus transdermal oestradiol and oral dydrogesterone, on lipid metabolism.
Schram JH; Boerrigter PJ; The TY
Maturitas; 1995 Sep; 22(2):121-30. PubMed ID: 8538480
[TBL] [Abstract][Full Text] [Related]
4. Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A1, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women.
Christodoulakos GE; Lambrinoudaki IV; Panoulis CP; Papadias CA; Kouskouni EE; Creatsas GC
Gynecol Endocrinol; 2004 May; 18(5):244-57. PubMed ID: 15346660
[TBL] [Abstract][Full Text] [Related]
5. Effects of tibolone or continuous combined oestradiol and norethisterone acetate on lipids, high-density lipoprotein subfractions and apolipoproteins in postmenopausal women in a two-year, randomized, double-blind, placebo-controlled trial.
Kotecha PT; Godsland IF; Crook D; Stevenson JC
Clin Endocrinol (Oxf); 2020 Apr; 92(4):303-311. PubMed ID: 31925799
[TBL] [Abstract][Full Text] [Related]
6. A 2-year study on the beneficial effects of 17 beta-oestradiol-dydrogesterone therapy on serum lipoproteins and Lp(a) in postmenopausal women: no additional unfavourable effects of dydrogesterone.
van der Mooren MJ; Demacker PN; Thomas CM; Borm GF; Rolland R
Eur J Obstet Gynecol Reprod Biol; 1993 Dec; 52(2):117-23. PubMed ID: 8157140
[TBL] [Abstract][Full Text] [Related]
7. The influence of transdermal oestradiol replacement therapy and medroxyprogesterone acetate on serum lipids and lipoproteins.
Bhathena RK; Anklesaria BS; Ganatra AM; Pinto R
Br J Clin Pharmacol; 1998 Feb; 45(2):170-2. PubMed ID: 9491833
[TBL] [Abstract][Full Text] [Related]
8. Effects of transdermal 17 beta-oestradiol combined with oral progestogen on lipids and lipoproteins in hypercholesterolaemic postmenopausal women.
Słowińska-Srzednicka J; Zgliczyński S; Chotkowska E; Srzednicki M; Stopińska-Głuszak U; Jeske W; Brzezińska A; Zgliczyński W; Sadowski Z
J Intern Med; 1993 Nov; 234(5):447-51. PubMed ID: 7693846
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular risk factors during sequentially combined 17 beta oestradiol and dydrogesterone (Femoston); results from a one-year study in postmenopausal women.
Gelfand M; Fugère P; Bissonnette F
Maturitas; 1997 Mar; 26(2):125-32. PubMed ID: 9089562
[TBL] [Abstract][Full Text] [Related]
10. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000.
Godsland IF
Fertil Steril; 2001 May; 75(5):898-915. PubMed ID: 11334901
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the effects of two continuous HRT regimens on cardiovascular risk factors.
Barnes JF; Farish E; Rankin M; Hart DM
Atherosclerosis; 2002 Jan; 160(1):185-93. PubMed ID: 11755937
[TBL] [Abstract][Full Text] [Related]
12. Effects of a lipid lowering fibrate and hormone replacement therapy on serum lipids and lipoproteins in overweight postmenopausal women with elevated triglycerides.
Nerbrand C; Nyberg P; Nordström L; Samsioe G
Maturitas; 2002 May; 42(1):55-62. PubMed ID: 12020980
[TBL] [Abstract][Full Text] [Related]
13. Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with 17beta-estradiol and dydrogesterone.
Lippuner K; Haenggi W; Birkhaeuser MH; Casez JP; Jaeger P
J Bone Miner Res; 1997 May; 12(5):806-12. PubMed ID: 9144347
[TBL] [Abstract][Full Text] [Related]
14. A randomised comparison of the effects of oral versus transdermal 17beta-oestradiol, each combined with sequential oral norethisterone acetate, on serum lipoprotein levels.
Spencer C; Crook D; Ross D; Cooper A; Whitehead M; Stevenson J
Br J Obstet Gynaecol; 1999 Sep; 106(9):948-53. PubMed ID: 10492107
[TBL] [Abstract][Full Text] [Related]
15. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
[TBL] [Abstract][Full Text] [Related]
16. Differential impact of conventional oral or transdermal hormone replacement therapy or tibolone on body composition in postmenopausal women.
Hänggi W; Lippuner K; Jaeger P; Birkhäuser MH; Horber FF
Clin Endocrinol (Oxf); 1998 Jun; 48(6):691-9. PubMed ID: 9713556
[TBL] [Abstract][Full Text] [Related]
17. Hormone replacement therapy and lipid-lipoprotein concentrations.
Gökmen O; Yapar Eyi EG
Eur J Obstet Gynecol Reprod Biol; 1999 Jul; 85(1):31-41. PubMed ID: 10428319
[TBL] [Abstract][Full Text] [Related]
18. Lipid effects of hormone replacement therapy with sequential transdermal 17-beta-estradiol and oral dydrogesterone.
Nieto JJ; Cogswell D; Jesinger D; Hardiman P
Obstet Gynecol; 2000 Jan; 95(1):111-4. PubMed ID: 10636512
[TBL] [Abstract][Full Text] [Related]
19. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
[TBL] [Abstract][Full Text] [Related]
20. [Plasma levels of total cholesterol, LDL-cholesterol, and HDL-cholesterol in postmenopausal women during 12 months' oral administration of dydrogesterone or medroxyprogesterone combined with continuous transdermal supplementation of 17beta-estradiol].
Milewicz T; Kostecka A; Rogatko I; Sztefko K; Kwiatkowska-Panek E; Radowick S; Krzysiek J
Przegl Lek; 2007; 64(2):65-9. PubMed ID: 17892034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
